Aeterna Zentaris
AEZS
$1.96
Share price
-1.01%
Change (1 day)
-38.75%
Change (1 year)
Categories
Operating Margin for Aeterna Zentaris (AEZS)
Operating Margin as of April 2024 (TTM): -161.15%
According to Aeterna Zentaris's latest financial reports and stock price the company's current Operating Margin is -161.15%. At the end of 2021 the company had an Operating Margin of -161.16%.
Operating Margin history for Aeterna Zentaris from 2001 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -161.16% | 24.61% |
| 2020 | -129.33% | -88.96% |
| 2019 | -1,171.05% | -3365.8% |
| 2018 | 35.86% | -101.63% |
| 2017 | -2,196.64% | -19.82% |
| 2016 | -2,739.74% | -70.27% |
| 2015 | -9,216.15% | -94.06% |
| 2014 | -155,236.36% | 35090.33% |
| 2013 | -441.13% | 627.55% |
| 2012 | -60.63% | -15.8% |
| 2011 | -72.01% | -14.08% |
| 2010 | -83.81% | 114.36% |
| 2009 | -39.10% | -74.35% |
| 2008 | -152.40% | 88.58% |
| 2007 | -80.82% | 53.24% |
| 2006 | -52.74% | -2287.19% |
| 2005 | 2.41% | -40.43% |
| 2004 | 4.05% | -136.32% |
| 2003 | -11.14% | -38% |
| 2002 | -17.97% | -46.99% |
| 2001 | -33.91% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 17.27% | -110.72% | 🇨🇭 Switzerland |
 Sanofi SNY | 18.21% | -111.30% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | 19.24% | -111.94% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | -109.76% | -31.89% | 🇺🇸 USA |
 Halozyme Therapeutics HALO | 37.47% | -123.25% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.